ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
13.64
+0.01 (0.07%)
At close: Aug 27, 2025, 4:00 PM
13.91
+0.27 (1.98%)
After-hours: Aug 27, 2025, 6:05 PM EDT
Company Description
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases.
Its lead product includes IMG-007, a non-depleting anti-OX40 mAb that has completed Phase 2a clinical trials for the treatment of atopic dermatitis and alopecia areata.
The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025.
ImageneBio, Inc. is headquartered in San Diego, California.
Contact Details
Address: 12526 High Bluff Drive, Suite 345 San Diego, California 92130 United States | |
| Phone | 617-901-7098 |
| Website | inmagenebio.com |
Stock Details
| Ticker Symbol | IMA |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001835579 |
| Employer ID | 81-1697316 |
| SIC Code | 2836 |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 12, 2025 | 8-K/A | [Amend] Current report |
| Aug 5, 2025 | 8-K | Current Report |
| Aug 4, 2025 | SCHEDULE 13G | Filing |
| Aug 4, 2025 | SCHEDULE 13G/A | Filing |
| Aug 1, 2025 | 8-K | Current Report |
| Jul 30, 2025 | SCHEDULE 13D/A | Filing |
| Jul 29, 2025 | SCHEDULE 13D/A | Filing |
| Jul 29, 2025 | 8-K | Current Report |
| Jul 28, 2025 | SCHEDULE 13D/A | Filing |
| Jul 25, 2025 | 8-K | Current Report |